3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
272
Leukemia
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
131
Lymphoma
108
Congenital Abnormalities
68
Myelodysplastic Syndromes
63
Leukemia, Myelomonocytic, Acute
60
Leukemia, Monocytic, Acute
58
Leukemia, Erythroblastic, Acute
56
Leukemia, Megakaryoblastic, Acute
54
Lymphoma, Non-Hodgkin
51
Burkitt Lymphoma
44
Lymphoma, Mantle-Cell
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Follicular
33
Leukemia, Myelomonocytic, Chronic
28
Anemia, Refractory, with Excess of Blasts
27
Hodgkin Disease
26
Recurrence
25
Lymphoma, Large-Cell, Immunoblastic
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Blast Crisis
24
Leukemia, Eosinophilic, Acute
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Myeloproliferative Disorders
17
Leukemia, Basophilic, Acute
17
Lymphoma, B-Cell, Marginal Zone
16
Leukemia, Promyelocytic, Acute
16
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Accelerated Phase
14
Interventions
Docetaxel
158
Prednisone
131
Leuprolide
95
bicalutamide
86
enzalutamide
83
Radiotherapy
80
Goserelin
80
Abiraterone Acetate
76
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
54
Magnetic Resonance Spectroscopy
46
Zoledronic Acid
44
gallium 68 PSMA-11
37
Flutamide
34
abiraterone
32
Estramustine
32
radium Ra 223 dichloride
30
apalutamide
27
Surveys and Questionnaires
26
Gonadotropin-Releasing Hormone
26
Androgen Antagonists
25
cabazitaxel
24
Radiosurgery
24
Dutasteride
22
sipuleucel-T
21
Prednisolone
21
Triptorelin Pamoate
20
Paclitaxel
20
luprolide acetate gel depot
19
Radiation
19
Exercise
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms
×
Cytarabine
×
Clear all
NCT00480090
2019-02-15
SLAP
University Health Network, Toronto
Phase 2
Completed
10 enrolled